Allison Dorval
CIK: 0001625110
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jun 12, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
Sale(S)Direct11.6K shares at avg. $7.20$84K - Jun 11, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
Award(A)Direct27K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Tender Offer(U)Direct13.3K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Disposition(D)DirectRestricted Stock Units
1.9K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Disposition(D)DirectRestricted Stock Units
33.8K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Disposition(D)DirectRestricted Stock Units
45K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
258K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
75K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
180K shares- - Jun 13, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
Sale(S)Direct11.6K shares at avg. $3.40$39K - Jun 11, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
Award(A)Direct27K shares- - Apr 2, 2025VERV
Verve Therapeutics, Inc.
Sale(S)Direct3.4K shares at avg. $4.15$14K - Apr 1, 2025VERV
Verve Therapeutics, Inc.
Exercise(M)Direct11.3K shares- - Jan 8, 2025VERV
Verve Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
75K shares- - Jan 8, 2025VERV
Verve Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
258K shares- - Jan 8, 2025VERV
Verve Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
45K shares- - Dec 2, 2024VERV
Verve Therapeutics, Inc.
Sale(S)Direct555 shares at avg. $5.64$3K - Nov 29, 2024VERV
Verve Therapeutics, Inc.
Exercise(M)Direct1.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 |  PBYI PUMA BIOTECHNOLOGY, INC. | Sale(S) | 11,610 | $7.20 | $83,579 | Direct |
| Jun 11, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | Award(A) | 27,000 | - | $0 | Direct |
| Jul 25, 2025 |  VERV Verve Therapeutics, Inc. | Tender Offer(U) | 13,280 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition(D) Restricted Stock Units | 1,875 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition(D) Restricted Stock Units | 33,750 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition(D) Restricted Stock Units | 45,000 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 258,000 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 75,000 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 180,000 | - | - | Direct |
| Jun 13, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | Sale(S) | 11,610 | $3.40 | $39,474 | Direct |
| Jun 11, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | Award(A) | 27,000 | - | - | Direct |
| Apr 2, 2025 | VERV Verve Therapeutics, Inc. | Sale(S) | 3,350 | $4.15 | $13,903 | Direct |
| Apr 1, 2025 | VERV Verve Therapeutics, Inc. | Exercise(M) | 11,250 | - | - | Direct |
| Jan 8, 2025 | VERV Verve Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 75,000 | - | - | Direct |
| Jan 8, 2025 | VERV Verve Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 258,000 | - | - | Direct |
| Jan 8, 2025 | VERV Verve Therapeutics, Inc. | Award(A) Restricted Stock Units | 45,000 | - | - | Direct |
| Dec 2, 2024 | VERV Verve Therapeutics, Inc. | Sale(S) | 555 | $5.64 | $3,130 | Direct |
| Nov 29, 2024 | VERV Verve Therapeutics, Inc. | Exercise(M) | 1,875 | - | $0 | Direct |
1-18 of 18 transactions
About Dorval Allison
Dorval Allison (SEC CIK 0001625110) files insider reports with the SEC as Director of PUMA BIOTECHNOLOGY, INC. (PBYI) and Chief Financial Officer of Verve Therapeutics, Inc. (VERV).
Signal8 holds 7 ownership filings by Dorval Allison, all Form 4s, filed between Dec 3, 2024 and Jun 15, 2026. Those filings report 18 transactions, from Nov 29, 2024 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dorval Allison's filings is in LOS ANGELES, CA.
Recent filings by Dorval Allison
- Jun 12, 2026: Open-market sale of PBYI shares (Form 4, code S).
- Jun 11, 2026: Grant or award of PBYI shares (Form 4, code A).
- Jul 25, 2025: Tender of shares transaction of VERV shares (Form 4, code U).
- Jul 25, 2025: Disposition to issuer transactions of VERV derivative securities (6 lines, Form 4, code D).
- Jun 13, 2025: Open-market sale of PBYI shares (Form 4, code S).
Other insiders filing for PUMA BIOTECHNOLOGY, INC. (PBYI)
- WILSON TROY EDWARD, Director
- Cesano Alessandra, Director
- AUERBACH ALAN H, President and CEO
- HUNT DOUGLAS M
- NOUGUES MAXIMO F, Chief Financial Officer
- Stuglik Brian M, Director